The rate of ketoacidosis among children younger than 5 years of age with type 1 diabetes is higher in Medicaid than commercial plans, finds new analysis.
Researchers found that pancreas volume, coupled with metabolic measures, can better predict disease progression of type 1 diabetes than either MRI imaging or glucose testing alone.
People with higher incomes and those in health plans with health savings accounts benefit more than others, according to research results published this week in the Annals of Internal Medicine. The research also showed no increase in insulin use,